Babbage reframes a decade-old controversy not as a story of national loss, but as a necessary collision between short-term political optics and long-term industrial reality. The piece's most striking claim is that the United Kingdom's decision to allow the 2016 sale of Arm to SoftBank was less a failure of sovereignty and more a pragmatic surrender to the brutal economics of chip design, where public markets often starve innovation of the capital it desperately needs.
The Poison Pill Paradox
The commentary begins by dissecting a fascinating strategic irony: Arm's historical refusal to manufacture its own chips was once its greatest shield against acquisition. Babbage notes that this "poison pill" successfully deterred giants like Nvidia, whose 2020 bid was ultimately blocked by competition authorities. However, the author points out a critical shift in strategy: "Arm might be swallowing its own poison pill" by launching its own CPU designs. This move fundamentally alters the company's neutrality, transforming it from a pure licensor into a direct competitor to its own customers.
This pivot is significant because it exposes the fragility of the "neutral architecture" model in an era of intense geopolitical competition. Babbage argues that by entering the design race, Arm risks alienating the very ecosystem that built its valuation. The author writes, "In the world of tech, the moment you stop investing you are on the verge of death. There is always something new to invest in," capturing the relentless pressure that forced SoftBank to push for deeper R&D.
The Brexit Context and Political Calculus
The piece then pivots to the 2016 sale, providing a granular look at the political vacuum left by the Brexit vote. Babbage argues that the timing was catastrophic for any attempt at intervention. "Prime Minister Theresa May said the deal between Softbank and ARM Holdings showed the UK economy could be successful after the country voted to leave the European Union," the author writes, highlighting how the government spun the sale as a vote of confidence.
This reframing is crucial for understanding why the deal proceeded despite concerns from figures like co-founder Hermann Hauser, who called it "a sad day for technology in Britain." Babbage suggests that Hauser's emotional appeal was powerless against the legal and political realities of the moment. The author explains that the UK government lacked the statutory tools to block the sale without clear national security grounds, a threshold that was difficult to meet for a licensing business.
"If SoftBank had been an aggressive American company or a French buyer, there might have been a more negative reaction, but a Japanese company was different. There was no way shareholders or the government could turn it down."
This observation underscores the unique diplomatic leverage SoftBank founder Masayoshi Son wielded. Babbage details how Son secured a meeting with top civil servant Jeremy Heywood, promising to double the UK workforce and keep the headquarters in Cambridge. The author notes that these promises were legally binding under the UK Takeover Code, and by 2021, the headcount had indeed doubled from 1,700 to over 3,500. This evidence effectively counters the narrative that the sale was a purely extractive move by a foreign buyer.
The Limits of National Ownership
However, the commentary does not shy away from the costs. Babbage acknowledges that while the investment was real, the center of gravity has undeniably shifted. "Looking at the Board of Directors in 2026 none seem to be based in the UK and all apart from Son seem to be based in the US," the author writes. This shift reflects a broader trend where chip design talent and capital are increasingly concentrated in the United States, a reality that no amount of political will can easily reverse.
Critics might note that Babbage underestimates the strategic value of retaining a sovereign design house, even if it is less profitable in the short term. In an era of "Chip Wars," having a domestic entity that controls the instruction set architecture (ISA) could provide a bargaining chip in trade negotiations or a lever to restrict technology flow to hostile states. Babbage dismisses this, arguing that "the Arm ISA and Arm designs could be used for any geopolitical purpose" is debatable, as stopping a license is far less effective than cutting off physical silicon supply.
Yet, the comparison to TSMC is instructive here. Unlike the Taiwanese giant, which builds massive fabrication plants that anchor local economies and supply chains, Arm's business model is intellectual property licensing. Babbage writes, "Arm isn't building huge fabs on a regular basis," suggesting that the UK never had the same "silicon shield" to lose. The loss of Arm is a loss of prestige and potential future upside, but perhaps not a loss of immediate industrial capacity.
The Apple Question
The piece concludes with a provocative speculation from the podcast hosts: that Apple might eventually ditch the Arm architecture for its own proprietary instruction set. Babbage writes, "Tim at the end of the podcast: that Apple should ditch the Arm ISA in favour of its own CPU ISA." This idea challenges the very foundation of Arm's business model, suggesting that even its most loyal customer may eventually seek total independence.
This possibility highlights the inherent tension in Arm's new strategy. By becoming a chip seller, Arm risks becoming a competitor to its biggest client, potentially accelerating the very fragmentation it hopes to avoid. The author's analysis of this dynamic adds a layer of forward-looking tension to the historical review.
"It's not great news but better to have a globally successful company with a major base in Cambridge than a failed one that has no operations outside the UK!"
Bottom Line
Babbage's strongest argument is the dismantling of the emotional narrative surrounding the 2016 sale, replacing it with a cold-eyed assessment of capital requirements and legal constraints. The piece effectively demonstrates that the UK government had little choice but to allow the deal, given the post-Brexit climate and the lack of legal mechanisms to intervene. However, the analysis is slightly vulnerable in its dismissal of the long-term strategic risks of ceding control of a critical technology standard to a foreign entity, a risk that may only become apparent as geopolitical tensions intensify. Readers should watch for how the new "chip seller" strategy plays out against Apple's potential move to a proprietary architecture, as this could redefine the global semiconductor landscape.